Prostate Health Index and multiparametric magnetic resonance imaging to predict prostate cancer grade reclassification in active surveillance

Published on Sep 1, 2020in BJUI4.806
· DOI :10.1111/BJU.15101
Zeyad Schwen15
Estimated H-index: 15
(JHUSOM: Johns Hopkins University School of Medicine),
Zeyad R. Schwen9
Estimated H-index: 9
(JHUSOM: Johns Hopkins University School of Medicine)
+ 7 AuthorsChristian P. Pavlovich51
Estimated H-index: 51
(JHUSOM: Johns Hopkins University School of Medicine)
Sources
Abstract
OBJECTIVE To identify the value of combining the Prostate Health Index (PHI) and multiparametric magnetic resonance imaging (mpMRI), tools which have previously been shown to be independently predictive of prostate cancer (PCa) grade reclassification (GR; Gleason score >6), for the purpose of predicting GR at the next surveillance biopsy to reduce unnecessary prostate biopsies for men in PCa active surveillance (AS). PATIENTS AND METHODS Between 2014 and 2019, we retrospectively identified 253 consecutive men in the Johns Hopkins AS programme who had mpMRI and PHI followed by a systematic ± targeted biopsy. PHI and PHI density (PHID) were evaluated across Prostate Imaging-Reporting and Data System version 2.0 (PI-RADSv2) scores and compared to those with and without GR. Next, the negative predictive value (NPV) and area under the receiver operating curve (AUC) were calculated to compare the diagnostic value of PI-RADSv2 score combined with PHI, PHID, or prostate-specific antigen density (PSAD) for GR using their respective first quartile as a cut-off. RESULTS Of the 253 men, 38 men (15%) had GR. Men with GR had higher PHI values (40.7 vs 32.0, P = 0.001), PHID (0.83 vs 0.57, P = 0.007), and PSAD (0.12 vs 0.10, P = 0.037). A PI-RADSv2 ≤3 alone had a NPV of 91.6% for GR (AUC 0.67). Using a PHI cut-off of 25.6 in addition to PI-RADSv2 ≤3, the NPV and AUC were both increased to 98% and 0.70, respectively. Using a PSAD cut-off of 0.07 ng/mL/mL with PI-RADSv2 had an AUC of 0.69 and NPV of 95.4%. PHI and PI-RADSv2 together could have avoided 20% of biopsies at the cost of missing 2.6% of GRs. CONCLUSIONS The combination of PHI and mpMRI can aid in the prediction of GR in men on AS and may be useful for decreasing the burden of surveillance prostate biopsies.
📖 Papers frequently viewed together
1 Citations
20204.81BJUI
References30
Newest
#1Nathan Perlis (UHN: University Health Network)H-Index: 8
#2Thamir Alkasab (UHN: University Health Network)H-Index: 2
Last. Neil Fleshner (UHN: University Health Network)H-Index: 73
view all 12 authors...
Purpose: Prostate cancer over diagnosis and overtreatment are concerns for clinicians and policy makers. Multiparametric magnetic resonance imaging and the PCA3 (prostate cancer antigen 3) urine test select for clinically significant cases. We explored how well the tests performed together with previous biopsies.Materials and Methods: In accordance with ethics committee approval we collected clinicopathological data on all patients in whom a PCA3 test was done from January 2011 to June 2016. Thi...
14 CitationsSource
#2Adam B. WeinerH-Index: 14
Last. Edward M. SchaefferH-Index: 59
view all 3 authors...
10 CitationsSource
#1Jeffrey J. Tosoian (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 29
#2Sasha C. Druskin (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 9
Last. Ashley E. Ross (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 52
view all 13 authors...
Objectives To explore the utility of prostate health index (PHI) density for detection of clinically-significant prostate cancer (PCa) in a contemporary cohort of men presenting for diagnostic workup of PCa. Patients & Methods The study cohort included patients with elevated PSA (>2 ng/ml) and negative digital rectal examination who underwent PHI testing and prostate biopsy at our institution in 2015. Serum markers were prospectively measured per standard clinical pathway. PHI was calculated as ...
33 CitationsSource
#1Arnout R. AlbertsH-Index: 9
#2Monique J. RoobolH-Index: 76
Last. Ivo G. Schoots (Erasmus University Medical Center)H-Index: 13
view all 7 authors...
Objectives To assess the value of risk-stratification based on magnetic resonance imaging (MRI) and prostate-specific antigen density (PSA-D) in reducing unnecessary biopsies without missing Gleason pattern 4 prostate cancer in men on active surveillance (AS). Patients and Methods In all, 210 men on AS with Gleason score 3 + 3 prostate cancer received a first MRI and if indicated [Prostate Imaging Reporting and Data System (PI-RADS) score ≥3] targeted biopsy (TBx) using MRI-transrectal ultrasono...
50 CitationsSource
#1Mufaddal Mamawala (Johns Hopkins University)H-Index: 13
#2Karthik Rao (Johns Hopkins University)H-Index: 4
Last. H. Ballentine Carter (Johns Hopkins University)H-Index: 79
view all 8 authors...
Objective To create a nomogram for men on active surveillance (AS) for prediction of grade re-classification (GR) above Gleason score 6 (Grade group >2) at surveillance biopsy. Patients and Methods From a cohort of men enrolled in an AS programme, a multivariable model was used to identify clinical and pathological parameters predictive of GR. Nomogram performance was assessed using receiver operating characteristic curves, calibration, and decision curve analysis. Results Of 1 374 men, 254 (18....
18 CitationsSource
#1Win Shun Lai (UAB: University of Alabama at Birmingham)H-Index: 7
#2Jennifer Gordetsky (UAB: University of Alabama at Birmingham)H-Index: 20
Last. Soroush Rais-Bahrami (UAB: University of Alabama at Birmingham)H-Index: 48
view all 5 authors...
BACKGROUND The objective of this study was to create a nomogram model integrating clinical and multiparametric magnetic resonance imaging (MP-MRI)–based variables to predict prostate cancer upgrading in a population of active surveillance (AS) patients. METHODS Prostate cancer patients on AS who underwent MP-MRI with magnetic resonance imaging (MRI)/ultrasound (US) fusion–guided biopsy were identified. Clinical and imaging variables, including the prostate-specific antigen density (PSAD), number...
43 CitationsSource
#2Robert H. BlackwellH-Index: 13
Last. Gopal N. GuptaH-Index: 26
view all 8 authors...
Abstract Purpose Using a combination of magnetic resonance imaging of the prostate and prostate specific antigen density, we aim to determine which men on active surveillance are at risk of being upstaged, and which men could avoid repeat biopsy while remaining on surveillance. Methods We reviewed 110 men on active surveillance with Gleason 6 disease who underwent magnetic resonance imaging followed by Uronav-fusion biopsy. Using univariable and multivariable logistic regression analyses, we exa...
2 CitationsSource
#1Marco Borghesi (UNIBO: University of Bologna)H-Index: 26
#2Hashim U. Ahmed (UCL: University College London)H-Index: 62
Last. Stacy Loeb (NYU: New York University)H-Index: 68
view all 8 authors...
Abstract Context Prostate biopsy (PB) represents the gold standard method to confirm the presence of cancer. In addition to traditional random or systematic approaches, a magnetic resonance imaging (MRI)–guided technique has been introduced recently. Objective To perform a systematic review of complications after transrectal ultrasound (TRUS)–guided, transperineal, and MRI-guided PB. Evidence acquisition We performed a systematic literature search of Web of Science, Embase, and Scopus databases ...
156 CitationsSource
#1Ting Martin Ma (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 9
#2Jeffrey J. Tosoian (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 29
Last. H. Ballentine Carter (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 79
view all 9 authors...
Abstract Background Multiparametric magnetic resonance imaging (mpMRI)/ultrasound fusion biopsy (targeted biopsy or TB) may improve detection of high-grade cancers when compared to systematic biopsy (SB). Objective To assess TB in active surveillance (AS). Design, setting, and participants We retrospectively evaluated SB (12-core sector) and TB among 103 AS men undergoing surveillance biopsy, 54 men undergoing confirmatory biopsy (CB), and 73 men referred for diagnostic biopsy (DB; comparison gr...
60 CitationsSource
#1Leonard P. Bokhorst (Erasmus University Medical Center)H-Index: 12
#2Riccardo ValdagniH-Index: 51
Last. Monique J. Roobol (Erasmus University Medical Center)H-Index: 76
view all 7 authors...
Abstract Background The Prostate Cancer Research International Active Surveillance (PRIAS) study was initiated a decade ago to study the most optimal selection and follow-up of men on active surveillance (AS). Objective We report on 10 yr of follow-up of men on AS in the PRIAS study and evaluate if criteria used to recommend a switch to active treatment truly predict unfavorable outcome on subsequent radical prostatectomy (RP). Design, setting, and participants Men with low-risk prostate cancer ...
181 CitationsSource
Cited By7
Newest
Resumen null null Objetivo null Determinar si el protocolo de vigilancia activa (VA) de nuestra institucion es una estrategia adecuada para minimizar el sobretratamiento del cancer de prostata. null null null Material y metodos null Analisis retrospectivo de 516 pacientes en VA tras el diagnostico de cancer de prostata. La poblacion se dividio en «VA por protocolo» vs. «VA inducida», dependiendo del cumplimiento de los criterios de inclusion del protocolo. Las prostatectomias radicales despues d...
Source
#1Paolo GandelliniH-Index: 25
Last. Nadia ZaffaroniH-Index: 66
view all 16 authors...
Active surveillance (AS) has evolved as a strategy alternative to radical treatments for very low risk and low-risk prostate cancer (PCa). However, current criteria for selecting AS patients are still suboptimal. Here, we performed an unprecedented analysis of the circulating miRNome to investigate whether specific miRNAs associated with disease reclassification can provide risk refinement to standard clinicopathological features for improving patient selection. The global miRNA expression profi...
Source
Early detection of prostate cancer (PC) is largely carried out using assessment of prostate-specific antigen (PSA) level; yet it cannot reliably discriminate between benign pathologies and clinically significant forms of PC. To overcome the current limitations of PSA, new urinary and serum biomarkers have been developed in recent years. Although several biomarkers have been explored in various scenarios and patient settings, to date, specific guidelines with a high level of evidence on the use o...
Source
#1Anna Saltman (University of Cincinnati Academic Health Center)
#2Joseph Zegar (University of Cincinnati Academic Health Center)
Last. Abhinav Sidana (UC: University of Cincinnati)H-Index: 15
view all 5 authors...
Several advancements have been made in recent years with regards to the detection and evaluation of prostate cancer (PCa). The low specificity of prostate specific antigen (PSA) has left much to be...
Source
#1James Liu (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 7
#2Hiten D. Patel (Loyola University Medical Center)H-Index: 23
Last. Alan W. Partin (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 124
view all 5 authors...
Early identification and management of prostate cancer completely changed with the discovery of prostate-specific antigen. However, improved detection has also led to overdiagnosis and consequently overtreatment of patients with low-risk disease. Strategies for the management of patients using active surveillance — the monitoring of clinically insignificant disease until intervention is warranted — were developed in response to this issue. The success of this approach is critically dependent on ...
Source
Resumen Objetivo Determinar si el protocolo de vigilancia activa (VA) de nuestra institucion es una estrategia adecuada para minimizar el sobretratamiento del cancer de prostata. Material y metodos Analisis retrospectivo de 516 pacientes en VA tras el diagnostico de cancer de prostata. La poblacion se dividio en «VA por protocolo» vs. «VA inducida», dependiendo del cumplimiento de los criterios de inclusion del protocolo. Las prostatectomias radicales despues de la VA fueron seleccionadas y estr...
Source
#2Raluca MunteanuH-Index: 5
Last. Ioan ComanH-Index: 11
view all 8 authors...
Prostate cancer represents the most encountered urinary malignancy in males over 50 years old, and the second most diagnosed after lung cancer globally. Digital rectal examination and prostatic specific antigen were the long-time standard tools for diagnosis but with a significant risk of overdiagnosis and overtreatment. Magnetic resonance imaging recently entered the diagnosis process, but to this date, there is no specific biomarker that accurately indicates whether to proceed with the prostat...
Source
#1Henrik Olsson (KI: Karolinska Institutet)H-Index: 13
#2Tobias Nordström (KI: Karolinska Institutet)H-Index: 16
Last. Anna Lantz (KI: Karolinska Institutet)H-Index: 5
view all 9 authors...
BACKGROUND Active surveillance (AS) for men with low-risk prostate cancer (PC) can lead to patient morbidity and healthcare overutilization. The aim of this study was to evaluate an AS protocol using the Stockholm3 test and magnetic resonance imaging (MRI) to reduce biopsy intensity. METHODS We conducted a prospective multicenter study of 280 invited men from a contemporary screening study (STHLM3), with Gleason Score (GS) 3 + 3 PC on a current AS protocol. Patients underwent prostate-MRI and bl...
2 CitationsSource
Source